Location · Kansas City, MO
Clinical trials in Kansas City, MO
328 recruiting studies have a site in the Kansas City area, and 75 of them accept healthy volunteers. The area includes Independence, Lee's Summit, North Kansas City, Liberty, Kansas City, KS, Overland Park, KS and nearby cities.
328 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
More recruiting studies (pay not posted)
- RecruitingPhase 3
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
AMAG Pharmaceuticals, Inc.
- Location
- Kansas City, MO + 3 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 3
Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial
Amgen
- Location
- Bridgeport, CT + 5 other US sites
- Eligibility basics
- Ages 35–80
- Recruiting
Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial (NEXT Trial)
Cerus Endovascular, Inc.
- Location
- Park Ridge, IL + 8 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Intellia Therapeutics
- Location
- Tucson, AZ + 36 other US sites
- Eligibility basics
- Ages 18–90
- Recruiting
Lumbar & Sacroiliac Fusion Study Involving Previously Implanted Devices
Spinal Simplicity LLC
- Location
- Overland Park, KS + 2 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Mirador Therapeutics, Inc.
- Location
- Birmingham, AL + 42 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
Amgen
- Location
- Los Angeles, CA + 4 other US sites
- Eligibility basics
- Ages 0 mo–18
- Recruiting
RELIVE (Randomized Evaluation of Less Invasive Ventricular Enhancement) Trial
BioVentrix
- Location
- Phoenix, AZ + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
Dimerix Bioscience Pty Ltd
- Location
- Phoenix, AZ + 19 other US sites
- Eligibility basics
- Ages 12–80
- Recruiting
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
Edwards Lifesciences
- Location
- Huntsville, AL + 49 other US sites
- Eligibility basics
- Ages 65+
- RecruitingPhase 2
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
Deciphera Pharmaceuticals, LLC
- Location
- Duarte, CA + 25 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
EnCompass Technologies, Inc.
- Location
- Indianappolis, IN + 4 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 1/Phase 2
A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease
GC Biopharma Corp
- Location
- Los Angeles, CA + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
Mezzion Pharma Co. Ltd
- Location
- Phoenix, AZ + 34 other US sites
- Eligibility basics
- Ages 12–18
- RecruitingPhase 3
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Kartos Therapeutics, Inc.
- Location
- Birmingham, AL + 57 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 4
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
Impax Laboratories, LLC
- Location
- Little Rock, AR + 22 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Sumitomo Pharma Switzerland GmbH
- Location
- Mobile, AL + 101 other US sites
- Eligibility basics
- Ages 18–50 · Women only
- RecruitingPhase 2
A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED
Glaukos Corporation
- Location
- Dothan, AL + 19 other US sites
- Eligibility basics
- Ages 2+
- RecruitingPhase 3
A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock (VBI-S-02)
Vivacelle Bio
- Location
- Chandler, AZ + 4 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
Modulation of SERCA2a of Intra-Myocytic Calcium Trafficking in Cardiomyopathy Secondary to Duchenne Muscular Dystrophy
Sardocor Corp.
- Location
- Kansas City, KS + 2 other US sites
- Eligibility basics
- Ages 18+ · Men only
- RecruitingPhase 4
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
Axsome Therapeutics, Inc.
- Location
- Bellflower, CA + 36 other US sites
- Eligibility basics
- Ages 18–65
- Recruiting
EMAGINE 2.0 - Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment
BrainQ Technologies Ltd.
- Location
- Downey, CA + 6 other US sites
- Eligibility basics
- Ages 22–80
- RecruitingPhase 1/Phase 2
A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)
Spirovant Sciences, Inc.
- Location
- Kansas City, KS + 3 other US sites
- Eligibility basics
- Ages 18–65
- Recruiting
Encore PFO Closure Device - The PerFOrm Trial
Encore Medical Inc.
- Location
- Little Rock, AR + 7 other US sites
- Eligibility basics
- Ages 18–60